Biotechnology
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

$257.5M

Market Cap • 11/18/2024

2018

(6 years)
Founded

2023

(1 year ago)
IPO

NASDAQ

Listing Exchange
Flag of US

New York

Headquarters • New York

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions
  • ...and much more!

    Get Premium